Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial

Richard Gray, Smitaa Patel, Natalie Ives* (Corresponding Author), Caroline Rick, Rebecca Woolley, Sharon Muzerengi, Alastair Gray, Crispin Jenkinson, Emma McIntosh, Keith Wheatley, Adrian Williams, C. E. Clarke, PD MED Collaborative Group

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences